LBTD OTC
Lotus Bio-Technology Development Corp.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -81.8%
5Y: +233.3%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$20K
+97.5% ▲
Net Income
-$20K
+97.5% ▲
EPS (Diluted)
$-0.00
+97.9% ▲
EBITDA
-$20K
+97.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $62K | $42K | $19K | $781K | $20K |
| Operating Expenses | $62K | $42K | $19K | $781K | $20K |
| Operating Income | -$62K | -$42K | -$19K | -$781K | -$20K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $59 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$62K | -$42K | -$19K | -$781K | -$20K |
| Tax Expense | $0 | $0 | $0 | $0 | $762K |
| Net Income | -$62K | -$42K | -$19K | -$781K | -$20K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.00 | $-0.00 | $-0.01 | $-0.00 |
| EBITDA | -$62K | -$42K | -$19K | -$780K | -$20K |
| Shares Outstanding | 6M | 6M | 181M | 83M | 83M |